Cordica Medical

Cordica Medical is a medical technology company focused on developing innovative transcatheter treatments for heart failure, specifically Heart Failure with Preserved Ejection Fraction (HFpEF). The company's lead technology is a proprietary implantable device designed to manage left atrial pressure and improve cardiac hemodynamics without the need for permanent shunting. Based in San Juan Capistrano, California, Cordica is led by a team of veteran medical device innovators with extensive experience in structural heart therapies. The company is currently advancing its lead program through the pre-clinical development phase with the goal of addressing a significant unmet need in cardiovascular medicine. Cordica's approach aims to provide a minimally invasive solution for a large patient population that currently has limited therapeutic options.